Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lumara Health, Inc.
Multicenter, randomized, double-blind, placebo-controlled trial evaluating different doses of transdermal estradiol delivered by sray to symptomatic postmenopausal women. The endpoints are the reduction in frequency and severity of hot flushes.
Age
35–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Post menopausal women,
Ages 35 or older,
Frequent moderate to severe hot flushes,
Qualifying general medical health
You may not be if
Disqualifying gynecological disorders,
Disqualifying dermatological disorders,
Disqualifying concurrent conditions
Clareo Health | Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms
